{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:57:26Z","timestamp":1789066646513,"version":"build-2803163510"},"reference-count":38,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82302269"],"award-info":[{"award-number":["82302269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82472037"],"award-info":[{"award-number":["82472037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Noninvasive detection of microglia is crucial for monitoring their spatiotemporal dynamics and facilitating early medical intervention during the prodromal stages of these neuroinflammatory diseases. Colony-stimulating factor 1 receptor (CSF1R) is a promising imaging biomarker for microglia in neuroinflammation. However, currently developed CSF1R-targeted probes lack [18F]-labeled variants, and their stability, sensitivity, and specificity are all suboptimal to some extent. In our study, based on pyrrolopyrimidines(a distinct structure of CSF1R inhibitors), we developed the [18F]-labeled CSF1R-targeted probe-18F-FPPA (6-(4-(2-(2-(2-(fluoro-18F)ethoxy)ethoxy)ethoxy)phenyl)-N-methyl-N-(3-methylbenzyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine).18F-FPPA was synthesized with a radiochemical yield of 4\u20137%, molar activity of 30\u201370 GBq\/\u03bcmol, and radiochemical purity exceeding 99%, which possesses excellent physicochemical properties, rapid blood pharmacokinetics (T1\/2\u03b1 = 2.50 min, T1\/2\u03b2 = 32.4 min), favorable invitro and in vivo stability, and a clear metabolic pathway via dual hepatobiliary and renal excretion. A marked uptake of 18F-FPPA was observed at the LPS injection site in the LPS group at 30\u201340 min postinjection. A decreased uptake also was observed in cold 19F-FPPA, BLZ945, and PLX3397 blocking groups (P &amp;lt; 0.05), and no obvious increase in the group of intraperitoneal injection of cyclosporine A (P &amp;gt; 0.05). The in vivo imaging and immunohistochemical results confirmed the specific uptake of 18F-FPPA by targeting CSF1R on microglia in inflamed tissues. Overall, our findings demonstrated that 18F-FPPA had great potential as a promising tracer for the imaging of neuroinflammatory diseases, while its unique binding profile also provides insights into CSF1R-targeted ligand development.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00276","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:04:18Z","timestamp":1787043858000},"page":"4571-4578","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation\nof 18F-FPPA as a Positron\nEmission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat\nModel of Neuroinflammation"],"prefix":"10.1021","volume":"23","author":[{"given":"Zhequan","family":"Fu","sequence":"first","affiliation":[{"name":"Zhongshan Hospital, Fudan University , , ,","place":["Shanghai, China, 200032"]},{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200030"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Lin","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Research and Trial Center , , ,","place":["Shanghai, China, 201210"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhejiang University , , ,","place":["Hangzhou, Zhejiang, China, 310058"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Su","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital, Fudan University , , ,","place":["Shanghai, China, 200032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoumi","family":"Hu","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200127"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200030"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5347-431X","authenticated-orcid":true,"given":"Rong","family":"Sheng","sequence":"additional","affiliation":[{"name":"Zhejiang University , , ,","place":["Hangzhou, Zhejiang, China, 310058"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200127"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-3273","authenticated-orcid":true,"given":"Dengfeng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Shanghai Clinical Research and Trial Center , , ,","place":["Shanghai, China, 201210"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"5","key":"2026090707080254400_cit1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"issue":"7","key":"2026090707080254400_cit2","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1021\/acs.jmedchem.3c02366","article-title":"Targeting the CSF-1\/CSF-1R Axis:\nExploring the Potential of CSF1R Inhibitors in Neurodegenerative Diseases","volume":"67","author":"Baek","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026090707080254400_cit3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/imcb.12301","article-title":"The role\nof innate immune responses\nand neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s\ndisease","volume":"98","author":"Webers","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"2026090707080254400_cit4","doi-asserted-by":"crossref","unstructured":"Adaikkan, C.; Islam, M. R.; Bozzelli, P. L.; Sears, M.; Parro, C.; Pao, P. C.; Sun, N.; Kim, T.; Abdelaal, K.; Sedgwick, M.; et al.; A multimodal approach of microglial\nCSF1R inhibition and GENUS provides therapeutic effects in Alzheimer\u2019s\ndisease mice.  bioRxiv: the preprint server\nfor biology2025. 10.1101\/2025.04.27.648471.","DOI":"10.1101\/2025.04.27.648471"},{"issue":"10","key":"2026090707080254400_cit5","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03084-7","article-title":"CSF1R signaling is a\nregulator of pathogenesis\nin progressive MS","volume":"11","author":"Hagan","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"2026090707080254400_cit6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bph.17341","article-title":"Anti-inflammatory\nand remyelinating effects of fexagratinib in experimental multiple\nsclerosis","volume":"182","author":"Gurski","year":"2025","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"2026090707080254400_cit7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06008-4","article-title":"A systems-level framework\nfor drug discovery identifies Csf1R as an anti-epileptic drug target","volume":"9","author":"Srivastava","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"2026090707080254400_cit8","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S2215-0366(20)30255-8","article-title":"Neuroinflammation in psychiatric\ndisorders: PET imaging\nand promising new targets","volume":"7","author":"Meyer","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"2026090707080254400_cit9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2967\/jnumed.119.229443","article-title":"Neuroinflammation\nPET Imaging: Current Opinion and\nFuture Directions","volume":"61","author":"Jain","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"4","key":"2026090707080254400_cit10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/glia.24664","article-title":"Microglial\nDepletion, a New Tool in Neuroinflammatory Disorders: Comparison of\nPharmacological Inhibitors of the CSF-1R","volume":"73","author":"Guenoun","year":"2025","journal-title":"Glia"},{"issue":"11","key":"2026090707080254400_cit11","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","article-title":"PET imaging\nof neuroinflammation in neurological disorders","volume":"19","author":"Kreisl","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"2026090707080254400_cit12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41380-024-02656-9","article-title":"PET imaging\nof neuroinflammation: any credible alternatives to TSPO yet?","volume":"30","author":"Chauveau","year":"2025","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"2026090707080254400_cit13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1182\/blood.2023022040","article-title":"CSF1R inhibition promotes\nneuroinflammation and behavioral deficits during graft-versus-host\ndisease in mice","volume":"143","author":"Adams","year":"2024","journal-title":"Blood"},{"key":"2026090707080254400_cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108565","article-title":"Repurposing\nof pexidartinib for microglia depletion and renewal","volume":"253","author":"Weyer","year":"2024","journal-title":"Pharmacol. Therapeutics"},{"key":"2026090707080254400_cit15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107066","article-title":"Repopulation of microglia\nand its\nimplications for CNS disorders: Insights from the single-cell era","volume":"215","author":"Chen","year":"2025","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"2026090707080254400_cit16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11674-z","article-title":"Sustained\nmicroglial depletion with CSF1R inhibitor\nimpairs parenchymal plaque development in an Alzheimer\u2019s disease\nmodel","volume":"10","author":"Spangenberg","year":"2019","journal-title":"Nat. Commun."},{"key":"2026090707080254400_cit17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.789834","article-title":"Insights Into\nthe Role of CSF1R in the Central Nervous System and Neurological Disorders","volume":"13","author":"Hu","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"2026090707080254400_cit18","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200187","article-title":"Global Presence and\nPenetrance of CSF1R-Related Disorder","volume":"10","author":"Dulski","year":"2024","journal-title":"Neurol.\nGenet."},{"issue":"5","key":"2026090707080254400_cit19","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1073\/pnas.1812155116","article-title":"PET imaging of microglia by targeting macrophage\ncolony-stimulating\nfactor 1 receptor (CSF1R)","volume":"116","author":"Horti","year":"2019","journal-title":"Proc. Natl. Acad.\nSci. U.S.A."},{"issue":"9","key":"2026090707080254400_cit20","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1177\/0271678X211004146","article-title":"PET imaging of colony-stimulating factor 1 receptor:\nA head-to-head comparison of a novel radioligand, (11)C-GW2580, and\n(11)C-CPPC, in mouse models of acute and chronic neuroinflammation\nand a rhesus monkey","volume":"41","author":"Zhou","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"2026090707080254400_cit21","doi-asserted-by":"publisher","DOI":"10.3390\/ph11040136","article-title":"Synthesis and Initial In Vivo Evaluation\nof [(11)C]AZ683-A Novel PET Radiotracer for Colony Stimulating Factor\n1 Receptor (CSF1R)","volume":"11","author":"Tanzey","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"3","key":"2026090707080254400_cit22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/jlcr.3827","article-title":"Efficient radiosynthesis\nand preclinical evaluation\nof [(18) F]FOMPyD as a positron emission tomography tracer candidate\nfor TrkB\/C receptor imaging","volume":"63","author":"Singleton","year":"2020","journal-title":"J. Labelled Compd.\nRadiopharm."},{"key":"2026090707080254400_cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2023.117233","article-title":"(18)F-Labeled\no-aminopyridyl alkynyl radioligands targeting colony-stimulating factor\n1 receptor for neuroinflammation imaging","volume":"83","author":"An","year":"2023","journal-title":"Bioorg.\nMed. Chem."},{"issue":"3","key":"2026090707080254400_cit24a","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030276","article-title":"Synthesis\nand Evaluation of a (18)F-Labeled Ligand for PET Imaging of Colony-Stimulating\nFactor 1 Receptor","volume":"15","author":"Lee","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"2026090707080254400_cit24b","doi-asserted-by":"publisher","first-page":"351","DOI":"10.62347\/qfgp5253","article-title":"H. Fully automated radiosynthesis of [(18)F]FCPPC for imaging microglia\nwith PET","volume":"14","author":"Roy","year":"2024","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"20","key":"2026090707080254400_cit24c","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1016\/j.bmcl.2014.09.014","article-title":"5-(4-((4-[(18)F]Fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine:\na selective dual inhibitor for potential PET imaging of Trk\/CSF-1R.","volume":"24","author":"Bernard-Gauthier","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"2026090707080254400_cit25","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1021\/acs.jmedchem.3c00428","article-title":"Synthesis and Development\nof Highly Selective Pyrrolo[2,3-d]pyrimidine CSF1R Inhibitors Targeting\nthe Autoinhibited Form","volume":"66","author":"Aarhus","year":"2023","journal-title":"J. Med. Chem."},{"issue":"12","key":"2026090707080254400_cit26","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1021\/cb400663k","article-title":"Conformation-selective\ninhibitors reveal differences in the activation and phosphate-binding\nloops of the tyrosine kinases Abl and Src","volume":"8","author":"Hari","year":"2013","journal-title":"ACS\nChem. Biol."},{"issue":"2","key":"2026090707080254400_cit27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/00498254.2014.945988","article-title":"Phenotypic and metabolic investigation of a CSF-1R kinase receptor\ninhibitor (BLZ945) and its pharmacologically active metabolite","volume":"45","author":"Krauser","year":"2015","journal-title":"Xenobiotica"},{"issue":"5","key":"2026090707080254400_cit28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.6026\/973206300200460","article-title":"Decoding\nthe anti-cancer potential of Pexidartinib (PLX3397), a Fms-like tyrosine\nkinase 3 inhibitor, using next-generation knowledge discovery methods","volume":"20","author":"Alreemi","year":"2024","journal-title":"Bioinformation"},{"issue":"1","key":"2026090707080254400_cit29","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae202","article-title":"Phase\n1b\/2 study of orally administered pexidartinib\nin combination with radiation therapy and Temozolomide in patients\nwith newly diagnosed glioblastoma","volume":"6","author":"Mendez","year":"2024","journal-title":"Neuro-Oncol.\nAdv."},{"issue":"5","key":"2026090707080254400_cit30","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1021\/acs.jmedchem.4c02933","article-title":"Discovery of Novel\nPyrrolo[2,3-b]pyridine-Based CSF-1R Inhibitors with Demonstrated Efficacy\nagainst Patient-Derived Colorectal Cancer Organoids","volume":"68","author":"He","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026090707080254400_cit31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114782","article-title":"Discovery of Pyrrolo[2,3-d]pyrimidine\nderivatives as\npotent and selective colony stimulating factor 1 receptor kinase inhibitors","volume":"243","author":"Liang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2\u20133","key":"2026090707080254400_cit32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-Glycoprotein,\na gatekeeper in the blood-brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv.\nDrug Delivery Rev."},{"key":"2026090707080254400_cit33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nucmedbio.2021.06.005","article-title":"BLZ945 derivatives\nfor PET imaging of colony stimulating factor-1 receptors in the brain","volume":"100\u2013101","author":"van der Wildt","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"2026090707080254400_cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128704","article-title":"[(11)C]NCGG401,\na novel PET ligand for imaging of colony stimulating\nfactor 1 receptors","volume":"65","author":"Ogata","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"2026090707080254400_cit35","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030276","article-title":"Synthesis\nand Evaluation of a (18)F-Labeled\nLigand for PET Imaging of Colony-Stimulating Factor 1 Receptor","volume":"15","author":"Lee","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"5","key":"2026090707080254400_cit36","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1073\/pnas.1812155116","article-title":"PET imaging\nof microglia by targeting macrophage colony-stimulating\nfactor 1 receptor (CSF1R)","volume":"116","author":"Horti","year":"2019","journal-title":"Proc. Natl. Acad.\nSci. U.S.A."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00276","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4571\/66773137\/acs.molpharmaceut.6c00276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4571\/66773137\/acs.molpharmaceut.6c00276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:29:06Z","timestamp":1788780546000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/9\/4571\/5270455\/Evaluation-of-18F-FPPA-as-a-Positron-Emission"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,18]]},"published-print":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00276","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}